• Olink® Target 96 Immuno-Oncology Panels

    Thoroughly validated, high-performance protein biomarker panels available for immuno-oncology studies.

    Olink® Target 96 panels specialize in key disease areas and important biological processes, and accelerate targeted protein biomarker research through high-multiplex immunoassays, providing uncompromised data quality and performance.

    icon-2

    Key features & benefits

    • Allows for simultaneous analysis of 92 protein biomarkers
    • Uses only 1 µL of biological sample
    • Exceptional data quality through relative (NPX) quantification
    • qPCR readout with unparalleled sensitivity, specificity, and precision
    • All assays are subject to Olink’s strict technical validation and quality control procedures

    Olink Target 96 Immuno-Oncology panels offer a broad selection of proteins associated with biological functions linked to immune response and immuno-oncology diseases. Categorization of the proteins included in the panel was carried out via referral to widely used public-access bioinformatic databases, including Uniprot, Human Protein Atlas, Gene Ontology (GO) and DisGeNET.

    Target

    Accelerate targeted protein biomarker research through high-multiplex immunoassays, providing uncompromised data quality and performance.
    Learn more about the Olink Target platform.

    Olink® Target 96 & 48

    How does it work?

    The unique technology behind the Olink platforms, Proximity Extension Assay (PEA) technology, is an innovative dual recognition, DNA-coupled methodology providing exceptional readout specificity. PEA enables high multiplex, rapid throughput biomarker analysis without compromising on data quality.

    PEA-image

    Read more about how Olink technology delivers this scale of multiplexing and sample throughput without compromising on data quality or assay robustness.

    Proximity Extension Assay (PEA) technology

    The Olink biomarker assay panels are available with the flexibility to best suit your needs. You can choose whether to purchase the panels as kits and run them in your own lab, or send your sample the experts at one of the many trained labs around the world offering sample analysis service.

    Panels

    Olink Target 96 Immuno-Oncology ( 92 )

    The biomarkers in this panel include proteins involved in processes such as promotion and inhibition of tumor immunity, chemotaxis, vascular & tissue remodelling, apoptosis & cell killing and metabolism & autophagy.

    The biomarker pages linked to below include calibrator curves that show the performance of each assay with the estimated sensitivity and dynamic range parameters indicated.

    ';
    Adenosine deaminase (ADA)
    ';
    Adhesion G-protein coupled receptor G1 (ADGRG1)
    ';
    Angiopoietin-1 (ANGPT1)
    ';
    Angiopoietin-1 receptor (TEK)
    ';
    Angiopoietin-2 (ANGPT2)
    ';
    Arginase-1 (ARG1)
    ';
    C-C motif chemokine 13 (CCL13)
    ';
    C-C motif chemokine 17 (CCL17)
    ';
    C-C motif chemokine 19 (CCL19)
    ';
    C-C motif chemokine 2 (CCL2)
    ';
    C-C motif chemokine 20 (CCL20)
    ';
    C-C motif chemokine 23 (CCL23)
    ';
    C-C motif chemokine 3 (CCL3)
    ';
    C-C motif chemokine 4 (CCL4)
    ';
    C-C motif chemokine 7 (CCL7)
    ';
    C-C motif chemokine 8 (CCL8)
    ';
    C-X-C motif chemokine 10 (CXCL10)
    ';
    C-X-C motif chemokine 11 (CXCL11)
    ';
    C-X-C motif chemokine 13 (CXCL13)
    ';
    C-X-C motif chemokine 5 (CXCL5)
    ';
    C-X-C motif chemokine 9 (CXCL9)
    ';
    CD27 antigen (CD27)
    ';
    CD40 ligand (CD40LG)
    ';
    CD70 antigen (CD70)
    ';
    CD83 antigen (CD83)
    ';
    Carbonic anhydrase 9 (CA9)
    ';
    Caspase-8 (CASP8)
    ';
    Cytotoxic and regulatory T-cell molecule (CRTAM)
    ';
    Decorin (DCN)
    ';
    Fibroblast growth factor 2 (FGF2)
    ';
    Fractalkine (CX3CL1)
    ';
    Galectin-1 (LGALS1)
    ';
    Galectin-9 (LGALS9)
    ';
    Granzyme A (GZMA)
    ';
    Granzyme B (GZMB)
    ';
    Granzyme H (GZMH)
    ';
    Growth-regulated alpha protein (CXCL1)
    ';
    Heme oxygenase 1 (HMOX1)
    ';
    Hepatocyte growth factor (HGF)
    ';
    ICOS ligand (ICOSLG)
    ';
    Interferon gamma (IFNG)
    ';
    Interleukin-1 alpha (IL1A)
    ';
    Interleukin-10 (IL10)
    ';
    Interleukin-12 (IL12A_IL12B)
    ';
    Interleukin-12 receptor subunit beta-1 (IL12RB1)
    ';
    Interleukin-13 (IL13)
    ';
    Interleukin-15 (IL15)
    ';
    Interleukin-18 (IL18)
    ';
    Interleukin-2 (IL2)
    ';
    Interleukin-33 (IL33)
    ';
    Interleukin-4 (IL4)
    ';
    Interleukin-5 (IL5)
    ';
    Interleukin-6 (IL6)
    ';
    Interleukin-7 (IL7)
    ';
    Interleukin-8 (CXCL8)
    ';
    Killer cell immunoglobulin-like receptor 3DL1 (KIR3DL1)
    ';
    Lymphocyte activation gene 3 protein (LAG3)
    ';
    Lysosome-associated membrane glycoprotein 3 (LAMP3)
    ';
    MHC class I polypeptide-related sequence A and MHC class I polypeptide-related sequence B (MICA_MICB)
    ';
    Macrophage colony-stimulating factor 1 (CSF1)
    ';
    Macrophage metalloelastase (MMP12)
    ';
    Matrilysin (MMP7)
    ';
    Mucin-16 (MUC16)
    ';
    Natural cytotoxicity triggering receptor 1 (NCR1)
    ';
    Natural killer cell receptor 2B4 (CD244)
    ';
    Natural killer cells antigen CD94 (KLRD1)
    ';
    Nitric oxide synthase, endothelial (NOS3)
    ';
    Placenta growth factor (PGF)
    ';
    Platelet-derived growth factor subunit B (PDGFB)
    ';
    Pleiotrophin (PTN)
    ';
    Pro-epidermal growth factor (EGF)
    ';
    Programmed cell death 1 ligand 1 (CD274)
    ';
    Programmed cell death 1 ligand 2 (PDCD1LG2)
    ';
    Programmed cell death protein 1 (PDCD1)
    ';
    Stromal cell-derived factor 1 (CXCL12)
    ';
    T-cell surface glycoprotein CD4 (CD4)
    ';
    T-cell surface glycoprotein CD5 (CD5)
    ';
    T-cell surface glycoprotein CD8 alpha chain (CD8A)
    ';
    T-cell-specific surface glycoprotein CD28 (CD28)
    ';
    Transforming growth factor beta-1 proprotein (TGFB1)
    ';
    Tumor necrosis factor (TNF)
    ';
    Tumor necrosis factor ligand superfamily member 10 (TNFSF10)
    ';
    Tumor necrosis factor ligand superfamily member 12 (TNFSF12)
    ';
    Tumor necrosis factor ligand superfamily member 14 (TNFSF14)
    ';
    Tumor necrosis factor ligand superfamily member 6 (FASLG)
    ';
    Tumor necrosis factor receptor superfamily member 12A (TNFRSF12A)
    ';
    Tumor necrosis factor receptor superfamily member 21 (TNFRSF21)
    ';
    Tumor necrosis factor receptor superfamily member 4 (TNFRSF4)
    ';
    Tumor necrosis factor receptor superfamily member 5 (CD40)
    ';
    Tumor necrosis factor receptor superfamily member 9 (TNFRSF9)
    ';
    Vascular endothelial growth factor A (VEGFA)
    ';
    Vascular endothelial growth factor receptor 2 (KDR)
    ';

    Olink Target 96 Immune Response ( 92 )

    The assays in this panel include proteins involved in key biological processes such as adaptive immune response, defense response to virus, lymphocyte activation, inflammatory response and cytokine-mediated signaling pathways.

    The biomarker pages linked to below include calibrator curves that show the performance of each assay with the estimated sensitivity and dynamic range parameters indicated.

    ';
    Allergin-1 (MILR1)
    ';
    Amphiregulin (AREG)
    ';
    Antiviral innate immune response receptor RIG-I (DDX58)
    ';
    Aryl hydrocarbon receptor nuclear translocator (ARNT)
    ';
    Baculoviral IAP repeat-containing protein 2 (BIRC2)
    ';
    Beta-galactosidase (GLB1)
    ';
    Butyrophilin subfamily 3 member A2 (BTN3A2)
    ';
    C-type lectin domain family 4 member A (CLEC4A)
    ';
    C-type lectin domain family 4 member C (CLEC4C)
    ';
    C-type lectin domain family 4 member D (CLEC4D)
    ';
    C-type lectin domain family 4 member G (CLEC4G)
    ';
    C-type lectin domain family 6 member A (CLEC6A)
    ';
    C-type lectin domain family 7 member A (CLEC7A)
    ';
    CD83 antigen (CD83)
    ';
    Contactin-associated protein-like 2 (CNTNAP2)
    ';
    Corneodesmosin (CDSN)
    ';
    Corticosteroid 11-beta-dehydrogenase isozyme 1 (HSD11B1)
    ';
    Coxsackievirus and adenovirus receptor (CXADR)
    ';
    Cytoskeleton-associated protein 4 (CKAP4)
    ';
    DNA fragmentation factor subunit alpha (DFFA)
    ';
    Diacylglycerol kinase zeta (DGKZ)
    ';
    Discoidin, CUB and LCCL domain-containing protein 2 (DCBLD2)
    ';
    Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide (DAPP1)
    ';
    Dynactin subunit 1 (DCTN1)
    ';
    E3 ubiquitin-protein ligase TRIM21 (TRIM21)
    ';
    Egl nine homolog 1 (EGLN1)
    ';
    Eotaxin (CCL11)
    ';
    Eukaryotic translation initiation factor 4 gamma 1 (EIF4G1)
    ';
    Eukaryotic translation initiation factor 5A-1 (EIF5A)
    ';
    FXYD domain-containing ion transport regulator 5 (FXYD5)
    ';
    Fc receptor-like protein 3 (FCRL3)
    ';
    Fc receptor-like protein 6 (FCRL6)
    ';
    Fibroblast growth factor 2 (FGF2)
    ';
    Hematopoietic lineage cell-specific protein (HCLS1)
    ';
    Histamine N-methyltransferase (HNMT)
    ';
    Importin subunit alpha-5 (KPNA1)
    ';
    Inactive dipeptidyl peptidase 10 (DPP10)
    ';
    Integral membrane protein 2A (ITM2A)
    ';
    Integrin alpha-11 (ITGA11)
    ';
    Integrin alpha-6 (ITGA6)
    ';
    Integrin beta-6 (ITGB6)
    ';
    Interferon lambda receptor 1 (IFNLR1)
    ';
    Interferon regulatory factor 9 (IRF9)
    ';
    Interleukin-1 receptor-associated kinase 1 (IRAK1)
    ';
    Interleukin-1 receptor-associated kinase 4 (IRAK4)
    ';
    Interleukin-10 (IL10)
    ';
    Interleukin-12 receptor subunit beta-1 (IL12RB1)
    ';
    Interleukin-5 (IL5)
    ';
    Interleukin-6 (IL6)
    ';
    Islet cell autoantigen 1 (ICA1)
    ';
    Keratin, type I cytoskeletal 19 (KRT19)
    ';
    Leukocyte immunoglobulin-like receptor subfamily B member 4 (LILRB4)
    ';
    Lymphocyte activation gene 3 protein (LAG3)
    ';
    Lymphocyte antigen 75 (LY75)
    ';
    Lysosome-associated membrane glycoprotein 3 (LAMP3)
    ';
    Mannan-binding lectin serine protease 1 (MASP1)
    ';
    Merlin (NF2)
    ';
    Methylated-DNA--protein-cysteine methyltransferase (MGMT)
    ';
    Natural cytotoxicity triggering receptor 1 (NCR1)
    ';
    Natural killer cells antigen CD94 (KLRD1)
    ';
    Neurabin-2 (PPP1R9B)
    ';
    Neurotrophin-4 (NTF4)
    ';
    Nuclear factor of activated T-cells, cytoplasmic 3 (NFATC3)
    ';
    PC4 and SFRS1-interacting protein (PSIP1)
    ';
    Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH1R)
    ';
    Peroxiredoxin-1 (PRDX1)
    ';
    Peroxiredoxin-5, mitochondrial (PRDX5)
    ';
    Phosphoinositide 3-kinase adapter protein 1 (PIK3AP1)
    ';
    Plexin-A4 (PLXNA4)
    ';
    Polypeptide N-acetylgalactosaminyltransferase 3 (GALNT3)
    ';
    Protein FAM3B (FAM3B)
    ';
    Protein HEXIM1 (HEXIM1)
    ';
    Protein kinase C theta type (PRKCQ)
    ';
    Protein sprouty homolog 2 (SPRY2)
    ';
    Protein-arginine deiminase type-2 (PADI2)
    ';
    SH2 domain-containing protein 1A (SH2D1A)
    ';
    SH2B adapter protein 3 (SH2B3)
    ';
    SRSF protein kinase 2 (SRPK2)
    ';
    Signaling threshold-regulating transmembrane adapter 1 (SIT1)
    ';
    Stanniocalcin-1 (STC1)
    ';
    Stromal cell-derived factor 1 (CXCL12)
    ';
    T-cell-specific surface glycoprotein CD28 (CD28)
    ';
    TNF receptor-associated factor 2 (TRAF2)
    ';
    TRAF family member-associated NF-kappa-B activator (TANK)
    ';
    Thioredoxin-dependent peroxide reductase, mitochondrial (PRDX3)
    ';
    Transcription factor AP-1 (JUN)
    ';
    Transcription regulator protein BACH1 (BACH1)
    ';
    Triggering receptor expressed on myeloid cells 1 (TREM1)
    ';
    Tripartite motif-containing protein 5 (TRIM5)
    ';
    Tryptase alpha/beta-1 (TPSAB1)
    ';
    Tumor necrosis factor receptor superfamily member EDAR (EDAR)
    ';
    Zinc finger and BTB domain-containing protein 16 (ZBTB16)
    ';

    Related documents

    A benchtop system for protein biomarker analysis

    Olink® Signature Q100 is a user-friendly instrument for readout of all Olink® Target and Olink® Focus protein biomarker panels. Learn more about this benchtop solution and how to streamline your protein biomarker analysis.

    Olink® Signature Q100
    Proteomics-and-transcriptomics

    Search for protein biomarker

    Browse the entire Olink library of high quality, thoroughly validated protein biomarker assays. Search by Uniprot ID, protein name, alternative protein name or gene name.

    Assay-Validation

    Validation Data

    To view more detailed information on Olink panels, you can download full validation data information for all Olink panels in the document download center.

    Product-news

    Manuals & instructions

    Access all the latest technical user documentation to learn more about the functionalities of Olink products and solutions, including manuals, short instructions and guidelines.

    Sample analysis service

    Sample analysis service

    Our analysis service offers high-capacity analysis of your samples using our Olink Explore or Olink Target platforms for protein biomarker analysis.

    FAQ-inline-1000x563

    Frequently Asked Questions

    See what other visitors asked, to learn more about Olink technology, services and science. Search our library of information or contact our Customer Support for assistance.

    2947

    Biomarker assays

    ~881 million

    Protein data points generated

    1281

    Publications listed on website

    Contact us!